February 23, 2018 / 1:04 PM / 8 months ago

BRIEF-Hemostemix Signs License Agreement With Aspire Health Science

Feb 23 (Reuters) - Hemostemix Inc:

* HEMOSTEMIX SIGNS LICENSE AGREEMENT WITH ASPIRE HEALTH SCIENCE

* HEMOSTEMIX INC - FINALIZED TERMS OF A LICENSE AGREEMENT WITH ASPIRE FOR CO'S LEAD THERAPEUTIC PRODUCT TECHNOLOGY, ACP-01

* HEMOSTEMIX INC - LICENSE AGREEMENT HAS INITIAL THREE YEAR TERM, WITH OPTIONS FOR CO TO RENEW FOR ADDITIONAL TWO YEAR EXTENSIONS

* HEMOSTEMIX-ASPIRE ‍HAS EXCLUSIVE RIGHTS TO USE, SELL, IMPORT ACP-01 IN THE BAHAMAS, COSTA RICA, DOMINICAN REPUBLIC, MEXICO, PANAMA AND STATE OF FLORIDA​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below